227 related articles for article (PubMed ID: 2652532)
1. Elective cyclosporine conversion from triple therapy.
Chapman JR; Allen RD; Ekberg H; Lawrence S; Stewart JH
Transplant Proc; 1989 Feb; 21(1 Pt 2):1631-2. PubMed ID: 2652532
[No Abstract] [Full Text] [Related]
2. Elective conversion from cyclosporine to azathioprine and prednisolone in patients after cadaveric renal transplantation: observations on graft survival and renal function.
Tegzess AM; van Son WJ; de Maar EF; Beelen JM; Sluiter WJ; Huisman RM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1635-7. PubMed ID: 2652534
[No Abstract] [Full Text] [Related]
3. Early conversion from cyclosporine to combination therapy with azathioprine in living related kidney transplantation.
Oka T; Omori Y; Aikawa I; Yasumura T; Yoshimura N; Yoshida T
Transplant Proc; 1989 Feb; 21(1 Pt 2):1628-30. PubMed ID: 2652531
[No Abstract] [Full Text] [Related]
4. A comparison of triple therapy with double therapy (cyclosporine/azathioprine) in low-risk, first cadaveric renal allograft recipients.
Restifo AC; Petrie JJ; Rigby RJ; Hardie IR; Jacob CK; Russ GR; Mathew TH
Transplant Proc; 1989 Feb; 21(1 Pt 2):1604-5. PubMed ID: 2652522
[No Abstract] [Full Text] [Related]
5. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
[No Abstract] [Full Text] [Related]
6. Immunosuppressive conversion from cyclosporine A to azathioprine in renal transplant patients.
Paraiso AR; Ona ET; Alano FA; Ramos CP; De Luna M
Transplant Proc; 1989 Feb; 21(1 Pt 2):1627. PubMed ID: 2652530
[No Abstract] [Full Text] [Related]
7. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
[No Abstract] [Full Text] [Related]
8. Is long-term therapy without cyclosporin A (CsA) indispensable or dangerous? One-year results of a prospective randomized trial.
Büsing M; Hölzer H; Schareck WD; Mellert J; Greger B; Hopt UT; Lauchart W
Transplant Proc; 1989 Feb; 21(1 Pt 2):1601-3. PubMed ID: 2652521
[No Abstract] [Full Text] [Related]
9. Cadaver renal transplantation without maintenance steroids.
Johnson RW; Mallick NP; Bakran A; Pearson RC; Scott PD; Dyer P; Donaghue D; Morris D; Gokal R
Transplant Proc; 1989 Feb; 21(1 Pt 2):1581-2. PubMed ID: 2652513
[No Abstract] [Full Text] [Related]
10. Effects of HLA matching and panel reactive antibodies in the development of rejection after conversion of cyclosporine to azathioprine.
Zemel SM; Shen SY; Weir MR; Dagher FJ; Bentley FR
Transplant Proc; 1987 Feb; 19(1 Pt 3):2029-31. PubMed ID: 3274466
[No Abstract] [Full Text] [Related]
11. Randomised trial of conversion from cyclosporin to azathioprine at one year after renal transplantation.
Watson MA; Briggs JD; Junor BJ; McMillan MA; Macpherson SG; Murray G; Stewart RM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1583-4. PubMed ID: 2652514
[No Abstract] [Full Text] [Related]
12. Long-term results of controlled cyclosporine conversion at 3 months after renal transplantation.
Kootte AM; van Dorp WT; van Bockel JH; van Es LA; Paul LC
Transplant Proc; 1989 Feb; 21(1 Pt 2):1585-6. PubMed ID: 2652515
[No Abstract] [Full Text] [Related]
13. Conversion to triple therapy in renal allograft patients with renal dysfunction and chronic interstitial lesions or vascular lesions on renal biopsy.
Leaker B; Neild GH; Rudge C; Mansell M; Thompson FD
Transplant Proc; 1989 Feb; 21(1 Pt 2):1548-9. PubMed ID: 2652501
[No Abstract] [Full Text] [Related]
14. Triple drug immunosuppression (cyclosporine, azathioprine and low-dose prednisolone): a safe and effective regimen in first-cadaver kidney transplantation.
Mourad G; Legendre C; Argiles A; Bonardet A; Mion C
Transplant Proc; 1987 Oct; 19(5):3672-3. PubMed ID: 3313886
[No Abstract] [Full Text] [Related]
15. Diagnosis of renal allograft rejection by analysis of infiltrating cell profiles: an assessment of cyclosporine, azathioprine/prednisolone, and triple therapy.
McWhinnie DL; Azevedo LS; Carter NP; Cranston D; Jones R; Wood RF; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 2):1633-4. PubMed ID: 3152633
[No Abstract] [Full Text] [Related]
16. Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients.
Ebel H; Lange H
Transplant Proc; 1987 Feb; 19(1 Pt 3):2005-6. PubMed ID: 3274463
[No Abstract] [Full Text] [Related]
17. Alternate-day cyclosporine A and azathioprine in experimental dog renal allografts.
Collier DS; Calne RY; De Curtins M; Thiru S; White DJ; Jamieson NV; Thick M; Barroso E
Transplant Proc; 1987 Feb; 19(1 Pt 2):1279-80. PubMed ID: 3274318
[No Abstract] [Full Text] [Related]
18. Triple low-dose immunosuppression with cessation of steroids in pediatric renal transplantation.
Walker RG; d'Apice AJ; Powell HR; Francis DM; Kincaid-Smith P
Transplant Proc; 1988 Feb; 20(1):7-10. PubMed ID: 3278465
[No Abstract] [Full Text] [Related]
19. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904
[No Abstract] [Full Text] [Related]
20. Combination therapy of cyclosporine and azathioprine in living-related kidney transplant recipients compared with patients converted totally from cyclosporine to azathioprine.
Oka T; Omori Y; Aikawa I; Yasumura T; Yoshimura N; Nakai I
Transplant Proc; 1988 Jun; 20(3 Suppl 3):143-6. PubMed ID: 3291229
[No Abstract] [Full Text] [Related]
[Next] [New Search]
